Nomura Adjusts Asymchem Laboratories' Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy
04:44 AM EDT, 04/26/2024 (MT Newswires) -- Nomura Adjusts Asymchem Laboratories' Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy Price (RMB): ¥80.99, Change: ¥+4.13, Percent Change: +5.37%
凱萊英:二零二四年第一季度報告
Gloria Ying (06821) spent about 19811,000 yuan to buy back 257,900 A shares on April 25
Gloria Ying (06821) announced that on April 25, 2024, it cost about 19811,000 yuan to buy 25.7...
Calculating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Asymchem Laboratories (Tianjin) fair value estimate is CN¥78.38 With CN¥77.32 share price, Asymchem Laboratories (Tianjin) appears to be trad
Gloria Ying (06821.HK) spent 69.754 million yuan to buy back 9062 million A shares on April 24
On April 24, Ge Longhui (06821.HK) issued an announcement. On April 24, 2024, it spent 69.754 million yuan to repurchase 9062 million A shares at a repurchase price of 75.53-77.58 yuan per share.
凱萊英:2023年度報告
Gloria Ying (06821.HK) spent 25 million yuan to buy back 327,000 A shares on April 23
On April 23, Ge Longhui (06821.HK) issued an announcement. On April 23, 2024, it spent 25 million yuan to repurchase 327,000 A shares at a repurchase price of 76.05-76.8 yuan per share.
Gloria Ying (06821) spent 24.997 million yuan to buy back 327,300 A shares on April 23
Gloria Ying (06821) announced that on April 23, 2024, the company spent RMB 2499.7...
Gloria Ying spent 44.5815 million yuan to buy back 588,800 A shares on April 19
Gloria Ying (06821) announced that on April 19, 2024, the company spent RMB 44.5815 million to repurchase 588,800 A shares at a repurchase price of 75.98-77 yuan per share.
Gloria Ying (06821) spent 44.5815 million yuan to buy back 588,800 A shares on April 19
Gloria Ying (06821) announced that on April 19, 2024, the company spent RMB 4458.1...
Gloria Ying (002821.SZ): It has an Intelligent Manufacturing Technology Center (CIMT) to enable intelligent management and manufacturing through artificial intelligence and data science
Gelonghui, April 18 | Gloria Ying (002821.SZ) said on the investor interactive platform that the company has an Intelligent Manufacturing Technology Center (CIMT) to empower intelligent management and manufacturing through artificial intelligence and data science, and is committed to process automation, intelligent production platforms, intelligent processing, operational integration, and active prediction capabilities.
Gloria Ying (06821.HK) plans to hold the 2023 annual results briefing on Panorama Network on April 22
Glonghui, April 17, 丨 Gloria Ying (06821.HK) announced that Gloria Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as the “Company”) disclosed the full text and summary of the 2023 Annual Report on March 29, 2024. In order to allow investors to further understand the company's business situation in 2023, the company is scheduled to hold the 2023 Annual Results Briefing (hereinafter referred to as the “Annual Results Briefing”) on April 22, 2024 (Monday) from 15:00-16:00 on Panorama Network. This annual results briefing will be held remotely via the Internet, and the company approved the paper
Gloria Ying (06821.HK) spent 19997 million yuan to buy back 258,300 A shares on April 15
On April 15, Ge Longhui (06821.HK) issued an announcement. On April 15, 2024, it spent RMB 19997 million to repurchase 258,300 A shares at a repurchase price of 76.78-77.75 yuan per share.
Gloria Eng (06821.HK) held a board meeting on April 25 to consider and approve the first quarter results
Glonghui, April 15, 丨 Gloria Ying (06821.HK) announced that the board of directors meeting will be held on April 25, 2024 (Thursday) to consider and approve (among other things) the first quarter results and announcements of the company and its subsidiaries for the three months ended March 31, 2024, and to consider the proposed payment of dividends (if any).
ASYMCHEM: DATE OF BOARD MEETING
Gloria Ying (002821.SZ): Fixed asset investment covers small business and various emerging business areas
Glonghui, April 15 | Gloria Ying (002821.SZ) said on the investor interactive platform that the company's fixed asset investment covers small business and various emerging business areas. For example, related projects include the steady progress of the Shanghai Fengxian Biomacromolecule commercial production base construction; the company is speeding up commercial peptide production capacity, which is expected to reach 14,250L by the end of the first half of 2024 to meet the commercial production needs of customers for solid phase peptides; at the same time, the company continues to strengthen new technology capabilities and production capacity reserves such as liquid phase synthesis and synthetic biology.
Gloria Ying (06821.HK) spent 295.22 million yuan to buy back 382,200 A shares on April 12
Glonghui, April 12 | Gloria Ying (06821.HK) announced that on April 12, it spent 295.22 million yuan to repurchase 382,200 A shares.
Gloria Ying spent 49.956 million yuan to buy back 628,900 A shares on April 11
Gloria Ying (06821) announced that on April 11, 2024, the company spent RMB 49.9956 million to repurchase 628,900 A shares at a repurchase price of RMB 78.8-80.0 per share.
Gloria Ying (06821) spent 49.956 million yuan to buy back 628,900 A shares on April 11
Gloria Ying (06821) announced that on April 11, 2024, the company spent RMB 4999.56...
Gloria Ying spent 29.9982 million yuan to buy back 367,800 A shares on April 10
Gloria Ying (06821) announced that on April 10, 2024, the company spent RMB 29.9982 million to repurchase 367,800 A shares, with a repurchase price of RMB 81.21-81.8 per share.
No Data